Hiroki Irie
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- Oncology 5
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Hiroshi Mizuta (5 shared papers)Junji Ide (2 shared papers)Mitsuharu Ueda (3 shared papers)Hirofumi Jono (2 shared papers)Yukio Ando (2 shared papers)Takanao Sueyoshi (1 shared paper)Akira Sei (2 shared papers)Katsumasa Takagi (5 shared papers)
- Journals
- Journal of Surgical Research (4 papers)Journal of Intensive Care (2 papers)Current Molecular Medicine (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Hiroki Irie
21 papers receiving 305 citations
Peers
Comparison fields: 5 of 64
- Nephrology 47
- Transplantation 15
- Rheumatology 37
- Molecular Biology 159
- Oncology 60
Countries citing papers authored by Hiroki Irie
This map shows the geographic impact of Hiroki Irie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Irie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Irie more than expected).
Fields of papers citing papers by Hiroki Irie
This network shows the impact of papers produced by Hiroki Irie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Irie. The network helps show where Hiroki Irie may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Irie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 112 | |
| 2 | 2009 | 26 | |
| 3 | 2020 | 26 | |
| 4 | 2004 | 17 | |
| 5 | 2015 | 17 | |
| 6 | 2008 | 14 | |
| 7 | 2003 | 14 | |
| 8 | 2014 | 14 | |
| 9 | 2001 | 13 | |
| 10 | 2019 | 12 | |
| 11 | 2010 | 9 | |
| 12 | 2023 | 7 | |
| 13 | 2018 | 6 | |
| 14 | 2005 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2002 | 4 | |
| 17 | 2014 | 3 | |
| 18 | 2011 | 3 | |
| 19 | 2014 | 2 | |
| 20 | [Breast sarcoidosis: 2 case reports and a review of 19 literature]. | 1994 | 2 |
About Hiroki Irie
Hiroki Irie is a scholar working on Molecular Biology, Oncology, Surgery, Genetics and Pathology and Forensic Medicine, having authored 21 papers that have together received 312 indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers), Cardiac Ischemia and Reperfusion (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers), Anesthesia and Neurotoxicity Research (2 papers), Total Knee Arthroplasty Outcomes (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Nephrology (47 citations), Transplantation (15 citations), Rheumatology (37 citations), Molecular Biology (159 citations) and Oncology (60 citations). Hiroki Irie has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroshi Mizuta, Junji Ide, Mitsuharu Ueda, Hirofumi Jono, Yukio Ando, Takanao Sueyoshi, Akira Sei, Katsumasa Takagi, Teiji Kato and Shinji Mizuarai. Their work appears in journals such as Journal of Surgical Research, Journal of Intensive Care, Current Molecular Medicine, Molecular Cancer Therapeutics and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.